Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The Senior Citizens League Says, "You Better Check Your Medicare Drug Plan"


News provided by

The Senior Citizens League

Oct 31, 2022, 11:36 ET

Share this article

Share toX

Share this article

Share toX

The Senior Citizens League
The Senior Citizens League

The recently enacted Inflation Reduction Act requires Medicare Part D plans to cap insulin costs at $35 per month per covered prescription starting in 2023. Diabetic Medicare beneficiaries need to confirm that their insulin will be covered by their plan next year before enrolling in a 2023 Drug Plan during Medicare Open Enrollment.

WASHINGTON, Oct. 26, 2022 /PRNewswire-PRWeb/ -- The recently enacted Inflation Reduction Act requires Medicare Part D plans to cap insulin costs at $35 per month per covered prescription starting in 2023, but to get the savings, diabetic Medicare beneficiaries first need to confirm that their insulin will be covered by their plan next year, warns the Senior Citizens League (TSCL). "If your insulin isn't covered by your plan, the $35 cap will not apply and you could wind up with thousands of dollars in pharmacy bills," says Mary Johnson, a Medicare, and Social Security policy analyst for The Senior Citizen League.

"Medicare Advantage and freestanding prescription drug plans make changes to their plans every year and can drop coverage of a drug without informing enrollees of the change in advance," says Johnson. During Medicare Open Enrollment, underway now through December 7, Medicare beneficiaries can learn about changes to their current plans, confirm coverage of drugs in their current plans, compare options for coverage in 2023, and switch plans if they can find a better match.

u201cIf your insulin isnu2019t covered by your plan, the $35 cap will not apply and you could wind up with thousands of dollars in pharmacy bills,u201d says Mary Johnson, a Medicare, and Social Security policy analyst for The Senior Citizen League.

Post this

For the past 17 years, Johnson has been helping friends and family check and compare their Medicare coverage options during the annual Medicare Open Enrollment Period. "Drug plans don't send their formularies by mail unless enrollees request a copy," Johnson says. Even with the list of covered drugs, plans can make changes after the formulary was printed. "Calling the plan's customer service number is one way to confirm continued coverage of your insulin in 2023, but it requires going through automated menus, getting put on hold, confusing terminology, and a process that can drive up your blood pressure," says Johnson.

Medicare's Drug Plan Finder, the online tool that can be useful in helping Medicare beneficiaries verify these details, carries a warning this year — "This new $35 cap may not be reflected when you compare 2023 plans. You should talk to someone for help comparing plans."

"We absolutely agree that help is needed this year, but many Medicare beneficiaries have no idea where to get experienced assistance with this task," Johnson says. "Free, unbiased help is available in almost every area of the country. Beneficiaries and other family members can find contact information online through their State Health Insurance Assistance Program (SHIP). Many of these programs operate through local Area Agencies on Aging and can help you over the phone or set up appointments for in-person visits. Do not put this task off. It is easy when you call and let a Medicare counselor do the work to get you through this," Johnson says.

Johnson's first case this Open Enrollment season is a neighbor who is enrolling in Medicare for the first time. He takes 10 prescription drugs, including two types of insulin — Humalog and Lantus. Johnson, who has experience doing drug plan searches, immediately hit a dead end on her first search attempt using the Medicare Drug Plan Finder. The initial results appeared to indicate that no drug plan in their area covered her neighbor's insulin prescriptions. Even worse, it appeared he might be on the hook for as much as $5,737.39 in premiums and out-of-pocket prescription costs next year. "Something wasn't right, but I was not sure at first what else to try," she said.

Johnson tried calling a few drug plans directly to learn more about the insulins that the plans offered on their formularies. "It was horrifying," says Johnson. "The calls took about an hour per call to confirm the prescribed insulins were covered by the drug plan. One of the plans had customer service representatives who answered questions about drug coverage in Medicare Advantage plans, even though information for free-standing Part D plans was specifically requested. One plan representative only disclosed the fact that she was discussing Medicare Advantage after the first 30 minutes. Even worse, the plan representative never confirmed what insulins the plan covered," Johnson says. "Another plan put me on hold after every single question but finally confirmed that Lantus at least, would be covered by their plan at $35 per month, even though the Medicare Plan Finder showed the generic version of Lantus was not covered by that plan."

"That call, however, was an ah-ha moment," said Johnson. "The drug input in the Medicare Drug Plan Finder automatically defaults to the generic name of the drug unless the user overrides it and clicks on 'brand.' My first search was unsuccessful because I had input the drugs allowing the generic default instead of selecting the brand names," she said. Johnson re-entered all the drug information and finally located a drug plan that appears to cover all her neighbor's prescriptions.

Even when the drug plan finder produces the list of drug plan choices, "the real work is just getting started," Johnson says. Additional effort is required to confirm which plans on the list cover all or at least most of the selected drugs. "Ten prescriptions can be a lot for any Part D plan to cover," says Johnson. The Drug Plan Finder provides a large amount of detail about whether the drug is covered, what "tier" it appears on in the formulary, and cost, but "this is another point where it helps to have a Medicare counselor along, who knows where to look up this information," Johnson says. "It's buried."

"If your insulin is covered by your drug plan formulary, then by law your insulin cost should be limited to $35 per covered prescription per month," Johnson says. Johnson was able to find an Anthem drug plan that covered 9 out of 10 of her neighbor's prescriptions and would cost her neighbor an estimated $2,007.67 in drug costs and premiums versus the $5,737.39 they found on their first search — still expensive, but big savings over the first attempt.

"The only uncovered drug, folic acid, is not usually covered by Part D plans," Johnson says, "but it costs less than $3 a month from Walmart, CVS, or Walgreens — less than most co-pays."

"When the top choice of drug plans covers most, but not all, of your drugs, it might still be the best you can do," Johnson says. "To lower the costs of drugs not covered by your plan, check for discount coupons from Good Rx.com," she says.

The last step after selecting a new plan for 2023? Call the number listed for the plan to confirm the drug coverage and cost information for the plan you are thinking about. "No escaping that step," Johnson says.

If all checks out, Johnson recommends enrolling in the selected plan through the Medicare website, rather than going through the insurance company's website or by phone. "Enrollment errors are reduced by using the Plan Finder, and for those who are switching from one plan to another, Medicare will make sure you are correctly dis-enrolled from your previous plan," Johnson says. "Hang on to your Medicare enrollment confirmation paperwork," she adds. "New enrollees will get their welcome package with their Part D enrollment card and premium payment information within a few weeks," she adds.

###

With 1.2 million supporters, The Senior Citizens League is one of the nation's largest nonpartisan seniors' groups. Its mission is to promote and assist members and supporters, to educate and alert senior citizens about their rights and freedoms as U.S. Citizens, and to protect and defend the benefits senior citizens have earned and paid for. The Senior Citizens League is a proud affiliate of TREA: The Enlisted Association. Visit http://www.SeniorsLeague.org for more information.

Media Contacts:
Shannon Benton - [email protected]
Mary Johnson - [email protected]

Media Contact

Shannon Benton, The Senior Citizens League, 703-548-5568, [email protected]

SOURCE The Senior Citizens League

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.